Loading insider details...
Beta
Latest Form 4 (Jun 8, 2026): Grant/Award of 75,000 PRME shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 8, 2026 | Prime Medicine, Inc. (PRME) | Grant/Award | 75,000 | n/a |
| Jun 3, 2026 | NEOGENOMICS INC (NEO) | Exercise/Conversion | 23,077 | n/a |
| May 14, 2026 | DMC Global Inc. (BOOM) | Grant/Award | 16,937 | n/a |
| Apr 27, 2026 | AMICUS THERAPEUTICS, INC. (FOLD) | Disposition to Issuer | 72,468 | $1.05M |
| Aug 6, 2025 | Prime Medicine, Inc. (PRME) | Disposition to Issuer | 13,510 | n/a |
| Jun 6, 2025 | AMICUS THERAPEUTICS, INC. (FOLD) | Grant/Award | 20,414 | n/a |
| Jun 5, 2025 | Prime Medicine, Inc. (PRME) | Grant/Award | 55,000 | n/a |
| Jun 3, 2025 | NEOGENOMICS INC (NEO) | Exercise/Conversion | 12,254 | n/a |
| May 28, 2025 | NEOGENOMICS INC (NEO) | Purchase | 5,000 | $38.0K |
| May 15, 2025 | DMC Global Inc. (BOOM) | Grant/Award | 17,580 | n/a |